PRFX News & Events

PRF Technologies announced positive results from a preclinical study in domestic pigs directly comparing its lead product candidate, PRF-110, to Zynrelef, an approved extended-release product used as a benchmark in the study. Key Results: PRF-110 and Zynrelef each produced clear reductions in pain-related measures, confirming post-operative analgesic activity for both extended-release local analgesic formulations. Across the overall 72-hour assessment period, PRF-110's analgesic effect was comparable to Zynrelef on the primary efficacy endpoints evaluated in this head-to-head preclinical setting. At later post-operative timepoints, PRF-110 maintained analgesic efficacy comparable to ZYNRELEF, supporting the sustained-release characteristics of PRF-110 following a single administration. PRF-110's safety and local tolerability profile in pigs was consistent with prior preclinical experience, with no unexpected findings observed at the doses tested.

PRF Technologies announced that the FDA has cleared the company's investigational new drug application for OcuRing-K, enabling the initiation of a Phase II clinical trial in patients undergoing cataract surgery.

PRF Technologies announced a commercial collaboration agreement with Blade Ranger designed to accelerate the commercial expansion of its DeepSolar platform across utility-scale solar portfolios. The commercial collaboration agreement is structured to support the introduction and negotiation of multiple large-scale commercial engagements for DeepSolar, each with a minimum scope of 150 MW. Blade Ranger operates at the intersection of renewable energy development, asset optimization, and infrastructure advisory, working alongside solar developers, independent power producers, institutional investors, and large-scale asset owners involved in solar infrastructure. PRF retains full discretion regarding the execution of any definitive commercial agreements resulting from the commercial collaboration agreement. Only binding agreements with paying customers will qualify under the structured engagement framework.